Skip to content

Does Endometrial Injury Improve Intrauterine Insemination Outcome?

Endometrial Injury May Increase the Pregnancy Rate in Patients Undergoing Intrauterine Insemination

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02542280
Enrollment
360
Registered
2015-09-07
Start date
2013-07-31
Completion date
2015-09-30
Last updated
2016-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Brief summary

The investigator suggests that local endometrial injury using pipelle catheter performed in the follicular phase (cycle day 5, 6 or 7) of the stimulation cycle may improve the pregnancy rates among patients undergoing intrauterine insemination.

Detailed description

In a selected group of patients with repeated implantation failure, endometrial injury in the preceding cycle may improve ICSI outcome. Little is known about the efficacy of this procedure in improving intrauterine insemination outcome. Also little is known about the effect of this procedure if done in the stimulation cycle weather in ICSI or intrauterine insemination cycles.

Interventions

PROCEDUREendometrial injury.

Endometrial injury using a pipelle biopsy catheter on day (5, 6 or 7) of the stimulation cycle combined with the intrauterine insemination.

PROCEDUREintrauterine insemination

Placement of washed sperm in the uterus using a catheter, around the time of ovulation.

DRUGovarian stimulation

Inducing ovulation by human menopausal gonadotrophin ampoules given intramuscular starting from cycle day two, till the leading follicle reaches 16 - 18 mm.

Sponsors

Ain Shams Maternity Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 38 Years
Healthy volunteers
No

Inclusion criteria

* 18 - 38 years. * patent fallopian tunes. * mild male factor. * anovulation. * unexplained infertility.

Exclusion criteria

* indications for ICSI. * evidence of pelvic inflammatory disease.

Design outcomes

Primary

MeasureTime frameDescription
Chemical Pregnancy Ratetwo weeks after intrauterine inseminationHuman chorionic gonadotrophin (b-hcg) detection in serum two weeks after intrauterine insemination.
Clinical Pregnancy Ratesix weeksUltrasound detection of an intrauterine positive fetal heart pulsations

Participant flow

Recruitment details

Patients were recruited from the infertility clinic and given appointments to go to the Assisted Reproductive Technology unit to start the process of IUI.

Pre-assignment details

11 patients were excluded because they did not show up for their appointments in assisted reproductive technology unit.

Participants by arm

ArmCount
Endometrial Injury
Endometrial injury during ovarian stimulation combined with intrauterine insemination. endometrial injury.: Endometrial injury using a pipelle biopsy catheter on day (5, 6 or 7) of the stimulation cycle combined with the intrauterine insemination. intrauterine insemination: Placement of washed sperm in the uterus using a catheter, around the time of ovulation. ovarian stimulation: Inducing ovulation by human menopausal gonadotrophin ampoules given intramuscular starting from cycle day two, till the leading follicle reaches 16 - 18 mm.
162
no Endometrial Injury
Ovarian stimulation combined with intrauterine insemination. intrauterine insemination: Placement of washed sperm in the uterus using a catheter, around the time of ovulation. ovarian stimulation: Inducing ovulation by human menopausal gonadotrophin ampoules given intramuscular starting from cycle day two, till the leading follicle reaches 16 - 18 mm.
167
Total329

Baseline characteristics

CharacteristicEndometrial Injuryno Endometrial InjuryTotal
Age, Continuous28.57 years
STANDARD_DEVIATION 3.99
29.52 years
STANDARD_DEVIATION 4.09
29.1 years
STANDARD_DEVIATION 4.1
BMI28.5 kg/m^2
STANDARD_DEVIATION 4
29.35 kg/m^2
STANDARD_DEVIATION 3.02
28.9 kg/m^2
STANDARD_DEVIATION 3.6
Region of Enrollment
Egypt
162 participants167 participants329 participants
Sex: Female, Male
Female
162 Participants167 Participants329 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1620 / 167
serious
Total, serious adverse events
0 / 1620 / 167

Outcome results

Primary

Chemical Pregnancy Rate

Human chorionic gonadotrophin (b-hcg) detection in serum two weeks after intrauterine insemination.

Time frame: two weeks after intrauterine insemination

ArmMeasureValue (NUMBER)
Endometrial InjuryChemical Pregnancy Rate40 participants
no Endometrial InjuryChemical Pregnancy Rate19 participants
Primary

Clinical Pregnancy Rate

Ultrasound detection of an intrauterine positive fetal heart pulsations

Time frame: six weeks

ArmMeasureValue (NUMBER)
Endometrial InjuryClinical Pregnancy Rate32 participants
no Endometrial InjuryClinical Pregnancy Rate13 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026